Abstract:Objective To evaluate a strategy of using TF siRNA loaded in a novel external stent prepared by hybrid uhrafine fibrous membrane consisting of PLGA/Chitosan nannoparticles as a therapy for vein graft disease.Methods Hybrid ultrafine fibrous membranes consisting of PLGA/Chitosan nannoparticles were fabricated via a specially designed electrospinning setup. After soaking in chloroform to dissolve PLGA. the amount of chitosan in the hybrid membranes was determined. The water uptake of the hybrid ultrafine fibrous membranes was investigated by incubation in phosphate buffer solution.Right jugular vein-carotid artery interposition grafting models in Spragne-Dawley rats were randomly divided into five groups:Group A(external stent consisting of PLGA/CS-TFsiRNA nanoparticles),Group B(external stent consisting of PLGA/CS.Stealth~(TM) RNAi negative control nanoparticles),Group C(external stent consisting of PLGA/CS blank nanoparticles),Group D(external stent consisting of PLGA),Group E(without perivenous extereal stent).BLOCK-iT~(TM) Fluorescent Oligo was used to confirm its stability and successful transfer into the vein graft wall.The vein grafts were harvested at 1,3,7,14,28 d after operation,respectively.The TF protein expression of vein grafts was analyzed by Westem blot and immunochemistry at 1,3,7 d after operation,respectively.The expression of proliferating cell nuclear antigen(PCNA)was identified by immunochemistry methods. The thickness of neointima at 28 d was calculatod by computer imaging analysis system. Results The PLGA and CS amount in PLGA/Chitosan nannoparticles membranes could be well controlled by adjusting the flow rate for electrospinning of PLGA and chitosan nannoparticles, respectively. Because of the introduction of chitosan,which is a naturally hydrophilic polymer,the hybrid membranes exhibited good water absorption properties.BIOCK-iT~(TM) Fluorescent Oligo could be detected in the graft wall even 12days after operation.The expression of TF protein in Group A Was significantly less than that in control groups at 3 d after operation(P＜0.05,0.40±0.03 vs 0.75 ±0.01、0.75 ±0.05、0.77 ±0.07)and at 7 d after operation(P＜0.05,0.30±0.03 vs 0.84±0.05、0.86±0.06、0.85±0.06).The expression of PCNA in Group A decreased significantly in comparison with control groups at 14 d after operation(P＜0.01,13.0%±2.6%vs 25.0%±2.8%、24.2%±3.9%、24.0%±4.1%、44.8%±3.7%).The thickness of neointima at 28 d after grafting in Group A Was significantly less than the untreated group(P＜0.01,18.8μm±2.9 μm vs 38.7 μm±5.0μm、37.3μm ±3.6 μm、37.2μm±2.6μm、67.5μm±4.8μm).Conclusion rrhe hovel external stent prepared by hybrid uhrafine fibrous membrane consisting of PLGA/Chitosan nannoparticles inhibits early neointima formation in rat vein grafts.This strategy may be a practicable and promising form of gene delivery against vein graft failure.

A Soft, Conductive External Stent Inhibits Intimal Hyperplasia in Vein Grafts by Electroporation and Mechanical Restriction

A Novel External Stent Prepared by Electospinning Reduces Neointimal Hyperplasia of Vein Grafts

A novel biodegradable external stent regulates vein graft remodeling via the Hippo-YAP and mTOR signaling pathways

Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts

Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature

Effects of the Different-Sized External Stents on Vein Graft Intimal Hyperplasia and Inflammation

Experimental Study of Saphenous Vein Grafts Restenosis Prevention by External Stents

Platelet Membrane-Encapsulated Poly(lactic- co-glycolic acid) Nanoparticles Loaded with Sildenafil for Targeted Therapy of Vein Graft Intimal Hyperplasia

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Polymer-based Delivering of Shrna to Rabbit Aortic Smooth Muscle Cells Suppressed the Expression of IGF-1R in Vitro and in Vivo.

A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

Endothelial Cell-Mediated Gene Delivery for In Situ Accelerated Endothelialization of a Vascular Graft

A Novel UV-curable Extravascular Stent to Prevent Restenosis of Venous Grafts

Local Gene Transfer of Tissue Inhibitor of Metalloproteinase-2 Influences Vein Graft Remodeling in a Mouse Model

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

3d Elastomeric Stent Functionalized with Antioxidative And Perivascular Tissue Regenerative Activities Ameliorated Pvt Deprivation‐Induced Vein Graft Failure

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Development of 3D printed electrospun vascular graft loaded with tetramethylpyrazine for reducing thrombosis and restraining aneurysmal dilatation

Construction of Tissue-Engineered Vascular Grafts with High Patency by Mimicking Immune Stealth and Blocking TGF-β Mediated Endothelial-to-mesenchymal Transition

Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia

A Novel Nanocellulose-Gelatin-AS-IV External Stent Resists EndMT by Activating Autophagy to Prevent Restenosis of Grafts